Vaxart, Inc short interest in 2024
In 2024, Vaxart, Inc's disclosed short interest ran from 7.55% of shares outstanding on 12 Jan 2024 to 5.09% on 31 Dec 2024, a change of -2.46 percentage points. The year's high was 11.50% on 14 Jun 2024 and its low 4.92% on 29 Nov 2024, averaging 7.50% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.02 days on 12 Jan 2024. Full history: Vaxart, Inc.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2024 in figures
- Start of year
- 7.55% (12 Jan 2024)
- End of year
- 5.09% (31 Dec 2024)
- Change
- -2.46 pp
- High
- 11.50% (14 Jun 2024)
- Low
- 4.92% (29 Nov 2024)
- Average
- 7.50%
- Highest days to cover
- 15.02 (12 Jan 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 7.55% | 15.02 | |
| 31 Jan 2024 | 7.31% | 2.88 | |
| 15 Feb 2024 | 8.33% | 7.51 | |
| 29 Feb 2024 | 9.02% | 6.00 | |
| 15 Mar 2024 | 8.98% | 10.80 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 9.89% | 9.70 | |
| 15 Apr 2024 | 10.55% | 9.94 | |
| 30 Apr 2024 | 10.62% | 13.60 | |
| 15 May 2024 | 10.70% | 12.43 | 10-Q filed, results (8-K) |
| 31 May 2024 | 10.88% | 14.36 | |
| 14 Jun 2024 | 11.50% | 2.39 | |
| 28 Jun 2024 | 8.02% | 1.27 | |
| 15 Jul 2024 | 7.12% | 5.30 | |
| 31 Jul 2024 | 6.95% | 9.12 | |
| 15 Aug 2024 | 5.94% | 6.57 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 5.60% | 3.45 | |
| 13 Sep 2024 | 5.56% | 8.18 | |
| 30 Sep 2024 | 5.31% | 7.94 | |
| 15 Oct 2024 | 5.16% | 12.90 | |
| 31 Oct 2024 | 4.96% | 12.12 | |
| 15 Nov 2024 | 5.04% | 6.11 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 4.92% | 8.34 | |
| 13 Dec 2024 | 4.96% | 8.14 | |
| 31 Dec 2024 | 5.09% | 5.12 |
See also: Vaxart, Inc's full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.